Michael Polark
Stock Analyst at Wolfe Research
(3.94)
# 1,871
Out of 5,126 analysts
173
Total ratings
50.8%
Success rate
6.5%
Average return
Main Sectors:
Stocks Rated by Michael Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Upgraded: Buy | $130 | $110.46 | +17.69% | 6 | Aug 13, 2026 | |
| A Agilent Technologies | Initiated Coverage: Hold | $135 | $177.88 | -24.11% | 1 | Jun 1, 2026 | |
| AVTR Avantor | Rated: Sell | $7 | $15.57 | -55.04% | 1 | Jun 1, 2026 | |
| BRKR Bruker | Downgraded: Hold | n/a | $62.24 | - | 1 | Jun 1, 2026 | |
| CAI Caris Life Sciences | Downgraded: Hold | n/a | $24.43 | - | 1 | Jun 1, 2026 | |
| DHR Danaher | Downgraded: Hold | n/a | $236.11 | - | 1 | Jun 1, 2026 | |
| MTD Mettler-Toledo International | Initiated Coverage: Hold | $1,180 | $1,751.38 | -32.62% | 1 | Jun 1, 2026 | |
| RGEN Repligen | Initiated Coverage: Buy | $145 | $173.98 | -16.66% | 1 | Jun 1, 2026 | |
| RVTY Revvity | Initiated Coverage: Hold | n/a | $159.10 | - | 1 | Jun 1, 2026 | |
| STVN Stevanato Group | Initiated Coverage: Buy | $21 | $13.53 | +55.21% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $535 | $718.20 | -25.51% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $425 | $475.52 | -10.62% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $375 | $412.55 | -9.10% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $44.70 | - | 6 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $92 | $104.01 | -11.55% | 8 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $62.31 | - | 15 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $47 | $40.91 | +14.89% | 1 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $101.59 | n/a | 6 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $13 | $12.69 | n/a | 11 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $17 | $16.27 | n/a | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 → $270 | $257.12 | n/a | 17 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $16.52 | n/a | 1 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $60 | $91.14 | n/a | 19 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $350 | $148.06 | n/a | 4 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $29.55 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $180 | $234.11 | n/a | 14 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $405 | $324.29 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $107.32 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $115 | $86.06 | n/a | 19 | Jun 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $6.43 | n/a | 1 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $121 → $140 | $79.92 | n/a | 2 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $155.30 | n/a | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $18.71 | n/a | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $315 | $450.04 | n/a | 9 | Apr 5, 2022 |
Abbott Laboratories
Aug 13, 2026
Upgraded: Buy
Price Target: $130
Current: $110.46
Upside: +17.69%
Agilent Technologies
Jun 1, 2026
Initiated Coverage: Hold
Price Target: $135
Current: $177.88
Upside: -24.11%
Avantor
Jun 1, 2026
Rated: Sell
Price Target: $7
Current: $15.57
Upside: -55.04%
Bruker
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $62.24
Upside: -
Caris Life Sciences
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $24.43
Upside: -
Danaher
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $236.11
Upside: -
Mettler-Toledo International
Jun 1, 2026
Initiated Coverage: Hold
Price Target: $1,180
Current: $1,751.38
Upside: -32.62%
Repligen
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $145
Current: $173.98
Upside: -16.66%
Revvity
Jun 1, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $159.10
Upside: -
Stevanato Group
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $13.53
Upside: +55.21%
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $535
Current: $718.20
Upside: -25.51%
Jun 1, 2026
Reiterated: Buy
Price Target: $425
Current: $475.52
Upside: -10.62%
Jun 1, 2026
Rated: Buy
Price Target: $375
Current: $412.55
Upside: -9.10%
May 29, 2026
Downgraded: Hold
Price Target: n/a
Current: $44.70
Upside: -
Apr 1, 2026
Upgraded: Buy
Price Target: $92
Current: $104.01
Upside: -11.55%
Feb 13, 2026
Downgraded: Hold
Price Target: n/a
Current: $62.31
Upside: -
Jan 12, 2026
Initiated Coverage: Buy
Price Target: $47
Current: $40.91
Upside: +14.89%
Aug 25, 2025
Reiterated: Hold
Price Target: n/a
Current: $101.59
Upside: n/a
Aug 14, 2025
Reiterated: Buy
Price Target: $14 → $13
Current: $12.69
Upside: n/a
Aug 8, 2025
Reiterated: Buy
Price Target: $19 → $17
Current: $16.27
Upside: n/a
Aug 8, 2025
Reiterated: Buy
Price Target: $245 → $270
Current: $257.12
Upside: n/a
May 29, 2025
Initiated Coverage: Buy
Price Target: $20
Current: $16.52
Upside: n/a
May 19, 2025
Upgraded: Buy
Price Target: $60
Current: $91.14
Upside: n/a
May 12, 2025
Upgraded: Buy
Price Target: $350
Current: $148.06
Upside: n/a
Mar 31, 2025
Initiated Coverage: Buy
Price Target: $29
Current: $29.55
Upside: n/a
Sep 17, 2024
Downgraded: Sell
Price Target: $180
Current: $234.11
Upside: n/a
Sep 9, 2024
Initiated Coverage: Buy
Price Target: $405
Current: $324.29
Upside: n/a
Sep 9, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $107.32
Upside: n/a
Jun 19, 2024
Upgraded: Buy
Price Target: $115
Current: $86.06
Upside: n/a
Oct 19, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $6.43
Upside: n/a
Jul 28, 2023
Reiterated: Buy
Price Target: $121 → $140
Current: $79.92
Upside: n/a
Apr 25, 2023
Downgraded: Hold
Price Target: n/a
Current: $155.30
Upside: n/a
Jan 26, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $18.71
Upside: n/a
Apr 5, 2022
Initiated Coverage: Hold
Price Target: $315
Current: $450.04
Upside: n/a